Harriet Kluger, MD
Professor of Medicine (Medical Oncology); Associate Cancer Center Director for Education and Training; Deputy Section Chief, Medical Oncology
Departments & Organizations
Medical Oncology: Subset Medical Oncology Faculty
Discovery to Cure Internship
Skin Diseases Research Center, Yale
WHRY Pilot Project Program Investigators
Yale Cancer Center: Developmental Therapeutics | Melanoma Program | Prostate & Urologic Cancers Program
Office of Cooperative Research
Biography
Dr. Kluger is a medical oncologist who sees patients with melanoma and renal cell carcinoma. Her research interests focus on developing new drug regimens and biomarkers predictive of response to therapies in melanoma and renal cell carcinoma. She participates in a number of clinical trials studying new agents for the treatment of these diseases, both targeting the immune system and the cancer cell. She runs and active research laboratory that studies tumor and immune cells from patients treated with novel therapies.
Education & Training
| MD | Tel Aviv University (1993) |
|---|---|
| Fellow | Yale University School of Medicine |
| Resident | University of New Mexico |
| Board Certification | AB of Internal Medicine, Medical Oncology (2002, recertified: 2012) |
